Anju Software has announced that Steve Rosenberg has joined the company's Board of Directors.
MMS Holdings announced the addition of Kevin Chartier, PhD, as Principal Advisor of Biostatistics and Submissions Planning.
Worldwide Clinical Trials announced the addition of Andrew Cunningham, PhD, Vice President, Bioanalytical; Ingela Danielsson-Sanden, MD, PhD, MBA, CHCQM, as Vice President of Early Phase Medical Management; and Austin Sansbury, MBA, PMP, as Strategic Projects Officer.
Greenphire announced that it has appointed Alan Matuszak as its new Chief Technology Officer.
THREAD announced the appointment of Scott Pearson as chief product officer.
IDDI celebrates its 30th anniversary this year.
CluePoints has announced it has won, in collaboration with BioNTech and Pfizer, the Clinical Advance of the Year category - COVID-19 Pandemic Special Recognition Award at the 17th Annual Scrip Awards.
CB Insights named Tendo Systems to its third annual Digital Health 150.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.